HEL 92.1.7 In Vitro ATP Assay (Cell Viability)

This assay is to provide HEL 92.1.7-based In Vitro ATP Assay (Cell Viability) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

HEL 92.1.7

Human

HEL 92.1.7 is a erythroblast cell line isolated from the bone marrow of a 30-year-old, White, male patient with erthroleukemia. This cell line can be used in immune system disorder research and immunology research.

Erythroleukemia

Oncology

In Vitro ATP Assay (Cell Viability)

HEL 92.1.7-cell based In Vitro ATP Assay (Cell Viability)

Adenosine triphosphate (ATP) assay is another widely used cell viability assay. When the cancer cells undergo apoptosis or necrosis upon treatment with a compound, cellular ATP content decreases and it can be quantified by colorimetric, fluorometric or luminometric way. The latest bioluminescence assays measure cellular ATP content using the enzyme luciferase which is more sensitive and reproducible when determining cell viability compared to conventional assays.

Adenosine Triphosphate Assay

Cell Viability/Cytotoxicity and Antiproliferative Assays

Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.

Cell Viability Assay

Cell-based Viability Assays Based on Cellular Enzymes and Proteins